RxDoctor Payments Data

Angela Nicolini, DO

Family Medicine · Stockton, CANPI 1013446228

Payments from drug & device makers

$1,463in general payments, 2019–2025

Across 72 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$316
  • Novo Nordisk$258
  • GSK$191
  • Pfizer$177
  • Lilly USA, LLC$162
  • Abbott$69
  • plus $290 from 10 others

What the payments were for

  • Food & beverage$1,463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,463 in reported general payments places this provider in the 75th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$115,768
Medicare patients
211
Services billed
1,485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide102$111,945
JardianceEmpagliflozin80$76,894
XareltoRivaroxaban32$33,787
EliquisApixaban48$30,704
JanuviaSitagliptin Phosphate51$28,492
TradjentaLinagliptin34$24,159
Janumet XrSitagliptin Phos/Metformin Hcl14$18,568
MounjaroTirzepatide18$18,454
RybelsusSemaglutide14$17,523
TrulicityDulaglutide20$17,161
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,547
VraylarCariprazine Hcl18$12,510
Effexor XrVenlafaxine Hcl12$9,730
Atorvastatin Calcium617$6,381
Atrovent HfaIpratropium Bromide13$5,795

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$258$129,467116 claims
PfizerEliquis, Effexor Xr$177$40,43560 claims
Lilly USA, LLCMounjaro, Trulicity$162$35,61638 claims
GSKTrelegy Ellipta$191$14,54723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,533 family medicine providers in California.

Other family medicine in Stockton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →